Aβ Cancer Research Results
Aβ, Aβ aggregation: Click to Expand ⟱
| Source: |
| Type: |
Beta-Amyloid (Aβ): In Alzheimer’s disease, Aβ peptides tend to misfold and aggregate into oligomers and fibrils.
|
Park, Parkinson's Disease (PD): Click to Expand ⟱
Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor and non-motor symptoms, and is due to the degeneration of dopaminergic neurons. It is multifactorial, caused by genetic and environmental factors and currently has no definitive cure.
-CoQ10 deficiency was observed at a higher frequency in Parkinson's disease
|
Scientific Papers found: Click to Expand⟱
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*neuroP↑, *antiOx↑, *ROS↓, *Inflam↓, *TNF-α↓, *IL1β↓, *PI3K↑, *Akt↑, *BBB↑, *NRF2↑, *SOD↑, *GPx↑, *MAPK↓, *Catalase↑, *HO-1↑, *COX2↓, *PGE2↓, *PPARγ↑, *TLR4↓, *GSK‐3β↓, *Aβ↓, *NLRP3↓, *BDNF↑, *TrkB↑, *GABA↑, *AChE↓, *Ach↑, *5HT↑, *cognitive↑, *MAOA↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
AntiCan↑, *neuroP↑, *cardioP↑, *AntiBio↑, *BioAv↑, *toxicity↓, *BioAv↑, *motorD↑, *SOD↑, *Catalase↑, *Keap1↑, *MDA↓, *GSH↑, *IL1β↓, *IL6↓, *TNF-α↓, *iNOS↓, *COX2↓, *lipid-P↓, *Cyt‑c↓, *ROS↓, *MMP↑, *antiOx↑, *AChE↓, *Apoptosis↓, *BAX↓, *Casp3↓, *Bcl-2↑, *BACE↓, *BChE↓, *eff↑, *Aβ↓, *ATP↑, RadioS↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Apoptosis↑, PARP↑, BAX↑, BID↑, NF-kB↑, Fas↑, EGFR↑, TIMP2↑, XIAP↓, COX2↓, Bak↓, Bcl-2↓, P53↑, HER2/EBBR2↓, FGF↓, CEA↓, Akt↓, TumCCA↑, *Imm↑, *CD4+↑, *CD8+↑, *BBB↑, *Pain↓, *cardioP↑, *TBARS↓, *SOD↑, *Catalase↑, *GSH↑, *AntiBio↑, *AntiFungal↑, *GastroP↑, *RenoP↑, *creat↓, *uricA↓, *Inflam↓, *iNOS↓, *COX2↓, *TNF-α↓, *IL6↑, *MMP13↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *memory↑, *Pain↓, *TRPV1↑, *Aβ↓, *tau↓, *cognitive↑, *Risk↓, *motorD↓, *ROS↓, *TNF-α↓, *IL1β↓, *eff↑, *Risk↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
*Aβ↓, *neuroP↑, *cardioP↑, *GastroP↑, *RenoP↑, *hepatoP↑, *Obesity↓, *Bacteria↓, *BioAv↑, *BioAv↑, *BioAv↑, *ROS↓, *GutMicro↑, *IBI↑, *MCT1↓, *NF-kB↓, *DNMT1↓,
| - |
in-vivo, |
AD, |
NA |
|
|
|
- |
in-vivo, |
Park, |
NA |
|
|
|
*neuroP↑, *TNF-α↓, *IL1β↓, *MDA↓, *Catalase↑, *GSH↑, *NRF2↑, *mtDam↓, *Inflam↓, *Apoptosis↓, *ROS↓, *cognitive↑, *Aβ↓, *BDNF∅, *APP↓, *BACE↓,
| - |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*neuroP↑, *Aβ↓, *ROS↓, *cognitive↑, *antiOx↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *BioAv↓, *AP-1↓, *NF-kB↓, *HATs↓, *HDAC↑, Dose↑, *ROS↓, *cognitive↑, *Aβ↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*ROS↓, *neuroP↑, *BDNF↑, *NRF2↑, *BBB↑, *HSPs↑, *GSH↑, *TG2/TGase↓, Aβ↓,
| - |
Review, |
Nor, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *ROS↓, *neuroP↑, *NO↑, BioAv↝, *BBB↑, *toxicity↑, *eff↑, *GSH↑, *SOD↑, *Aβ↓, *12LOX↓, *COX2↓, *Catalase↑, *Inflam↓, *TNF-α↓, *IL6↑, *lipid-P↓, NF-kB↓, IL1β↓, NRF2↑, HO-1↑, GSTs↑, cognitive↑, *BDNF↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *motorD↑, *Aβ↓, *p‑tau↓, *cognitive↑, *memory↑, *ERK↑, *p‑Akt↑, *PPARγ↑, *PGC-1α↑, *MMP↑, *mt-ROS↓, *SIRT3↑, *IL1β↓, *TNF-α↓, *GRP78/BiP↓, *CHOP↓, *NF-kB↓, *GSK‐3β↓, *β-catenin/ZEB1↑, *Ca+2↓, *AChE↓, *SOD↑, *Catalase↑, *GPx↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
NA, |
Park, |
NA |
|
|
|
*BDNF↑, *hepatoP↑, *ALAT↓, *AST↓, *TNF-α↓, *SIRT3↑, *Aβ↓, *Apoptosis↓, *ROS↓, *MMP↑, *Ca+2↓, *Casp3↓, *Ach↑, *PPARγ↑, *PGC-1α↑, *motorD↑, *TNF-α↓, *IL1β↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
MS, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *BioAv↝, *BBB↑, *TNF-α↓, *IL1β↓, *IL6↓, *IL8↓, *IL33↓, *NF-kB↓, *BACE↓, *ROS↓, *SOD↑, *HO-1↑, *NRF2↑, *Casp3↓, *Casp9↑, *Bax:Bcl2↓, *UPR↑, *GRP78/BiP↑, *Aβ↓, *GSK‐3β↓, *tau↓, *CREB↑, *ATP↑, *cognitive↑, *BloodF↑, *BDNF↑, *TrkB↑, *memory↑, *PPARγ↑, *eff↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
proCasp9↓, CDC2↓, CycB/CCNB1↓, Casp9↑, Casp3↑, Cyt‑c↑, cycA1/CCNA1↑, CDK2↓, APAF1↑, TumCCA↑, P53↑, BAX↑, VEGF↓, Bcl-2↓, Apoptosis↑, p‑Akt↓, p‑EGFR↓, p‑ERK↓, p‑STAT3↓, cardioP↑, Catalase↓, SOD↓, *BioAv↓, *antiOx↑, *ROS↓, *NO↓, *GSTs↑, *GSR↑, *SOD↑, *Catalase↑, *lipid-P↓, PI3K↓, Akt↓, CDK2↓, BNIP3↑, hTERT/TERT↓, DR5↑, Beclin-1↑, TNF-α↓, NF-kB↓, IL1↓, IL6↓, EMT↓, FAK↓, E-cadherin↑, MDM2↓, NOTCH↓, MAPK↑, Vim↓, N-cadherin↓, Snail↓, MMP2↓, Twist↓, MMP9↓, ROS↑, MMP↓, *AChE↓, *MMP↑, *Aβ↓, *neuroP↑, Trx1↑, ROS↓, *NRF2↑, NRF2↓, *BBB↑, ChemoSen↑, GutMicro↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
JAK↓, STAT↓, Inflam↓, NO↓, COX2↓, CRP↓, selectivity↑, *neuroP↑, STAT3↓, cycD1/CCND1↓, MMP2↓, STAT4↓, JAK2↓, TumCP↓, Diff↓, *eff↑, *IL6↓, *TNF-α↓, *IL1β↓, *Aβ↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*OS↑, *memory↑, *cognitive↑, *memory↑, *Aβ↓, *eff↑, *HSF1↑, *HSP70/HSPA5↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*Inflam↓, *antiOx↑, *neuroP↑, *IL6↓, *IL1β↓, *NF-kB↓, *PGE2↓, *COX2↓, *MMP↑, *memory↑, *ROS↓, *Aβ↓, *HMGB1↓, TumCG↓, MARK4↓, Zeb1↓, MDM2↓, BNIP3↑, ASC↑, NLRP3↓, PI3K↓, Akt↓, Casp1↓, E-cadherin↑, STAT3↓, TLR4↓, MMP↓, ICAM-1↓, AMPK↓, IL6↑, MMP2↓, Warburg↓, Bcl-xL↓, Bcl-2↓, TumCCA↑, EMT↓, TumMeta↓, mTOR↓, HSP27↓, Casp3↑, GlucoseCon↓, lactateProd↓, VEGF↓, p‑p65↓, GIT1↓, FOXM1↓, cycD1/CCND1↓, CDK4↓, MMP9↓, HDAC2↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
*antiOx↑, *Inflam↓, *Half-Life↝, *NRF2↑, *NQO1↑, *HO-1↑, *TrxR↑, *ROS↓, *TNF-α↓, *IL1β↓, *IL6↓, *iNOS↓, *COX2↓, *Aβ↓, *GSH↑, *cognitive↑, *BACE↓, *HSP70/HSPA5↑, *neuroP↑, *ROS↓, *BBB↑, *MMP9↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *ROS↓, *Inflam↓, *Apoptosis↓, *BBB?, *tau↓, *NF-kB↓, *IL1β↓, *TNF-α↓, *IL4↓, *MAPK↓, *memory↑, *cognitive↑, *Aβ↓, *ROS↓, *lipid-P↓, *GSH↑, *MDA↓, *SOD↑, *Catalase↑, *AChE↓, *BChE↓, *p‑ERK↓, *p‑JNK↓, *p‑p38↓, *GutMicro↑, *COX2↓, *iNOS↓, *TLR4↓, *neuroP↑, *Strength↑, *AMPK↑, *MMP↑, *necrosis↓, *NRF2↑, *HO-1↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*MitoP↑, *Inflam↓, *antiOx↑, *Risk↓, *Aβ↓, *p‑tau↓, *p62↓, *PARK2↑, *MMP↑, *ROS↓, *Strength↑, *CRP↓, *IL1β↓, *IL6↓, *TNF-α↓, *AMPK↑, *NF-kB↓, *MAPK↓, *p62↑, *NRF2↑, *SOD↑, *Catalase↑, *HO-1↑, *Ferroptosis↓, *lipid-P↓, *Cartilage↑, *PI3K↓, *Akt↓, *mTOR↓, *Apoptosis↓, *neuroP↑, *Bcl-2↓, *BAX↑, *Casp3↑, *ATP↑, *eff↑, *motorD↑, *NLRP3↓, *radioP↑, *BBB↑,
| - |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
*Inflam↓, *antiOx↓, *neuroP↑, *p‑tau↓, *Aβ↓, *eff↑, *BioAv↓, *BioAv↑, *GSH↑, *SOD↑, *lipid-P↓, *Catalase↑, *GSR↑, *GPx↑, *ROS↓, *NRF2↑, *GutMicro↑, *Risk↓, *BBB↓, *NLRP3↓, *MAOA↓,
Showing Research Papers: 1 to 21 of 21
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 21
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Catalase↓, 1, GSTs↑, 1, HO-1↑, 2, NRF2↓, 1, NRF2↑, 2, ROS↓, 1, ROS↑, 2, SOD↓, 1, Trx1↑, 1,
Mitochondria & Bioenergetics ⓘ
CDC2↓, 1, mitResp↓, 1, MMP↓, 2, mtDam↑, 1, XIAP↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↓, 1, cMyc↓, 1, GlucoseCon↓, 1, Glycolysis↓, 1, lactateProd↓, 1, Warburg↓, 1,
Cell Death ⓘ
Akt↓, 4, p‑Akt↓, 1, APAF1↑, 1, Apoptosis↑, 2, Bak↓, 1, BAX↑, 2, Bax:Bcl2↑, 1, Bcl-2↓, 3, Bcl-xL↓, 1, BID↑, 1, Casp1↓, 1, Casp3↑, 4, Casp8↑, 1, Casp9↑, 3, proCasp9↓, 1, Cyt‑c↑, 2, DR5↑, 1, Fas↑, 1, hTERT/TERT↓, 1, MAPK↑, 1, MDM2↓, 2,
Kinase & Signal Transduction ⓘ
HER2/EBBR2↓, 1,
Protein Folding & ER Stress ⓘ
HSP27↓, 1,
Autophagy & Lysosomes ⓘ
Beclin-1↑, 1, BNIP3↑, 2,
DNA Damage & Repair ⓘ
P53↑, 2, p‑P53↑, 1, PARP↑, 2, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 3, CDK4↓, 1, cycA1/CCNA1↑, 1, CycB/CCNB1↓, 1, cycD1/CCND1↓, 3, TumCCA↑, 4,
Proliferation, Differentiation & Cell State ⓘ
Diff↓, 1, EMT↓, 2, EMT↝, 1, p‑ERK↓, 1, FGF↓, 1, FOXM1↓, 1, p‑GSK‐3β↓, 1, HDAC2↓, 1, mTOR↓, 2, NOTCH↓, 1, PI3K↓, 3, STAT↓, 1, STAT3↓, 2, p‑STAT3↓, 1, STAT4↓, 1, TumCG↓, 2,
Migration ⓘ
CEA↓, 1, E-cadherin↑, 3, FAK↓, 1, GIT1↓, 1, MARK4↓, 1, MMP2↓, 3, MMP9↓, 2, N-cadherin↓, 2, Snail↓, 1, TIMP2↑, 1, TumCP↓, 1, TumMeta↓, 1, Twist↓, 1, Vim↓, 1, Zeb1↓, 1,
Angiogenesis & Vasculature ⓘ
EGFR↑, 1, p‑EGFR↓, 1, Hif1a↓, 1, NO↓, 1, VEGF↓, 3,
Immune & Inflammatory Signaling ⓘ
ASC↑, 1, COX2↓, 2, CRP↓, 1, ICAM-1↓, 1, IL1↓, 1, IL1β↓, 1, IL6↓, 1, IL6↑, 1, Inflam↓, 1, JAK↓, 1, JAK2↓, 1, NF-kB↓, 2, NF-kB↑, 1, p‑p65↓, 1, TLR4↓, 1, TNF-α↓, 1,
Protein Aggregation ⓘ
Aβ↓, 1, NLRP3↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↝, 1, ChemoSen↑, 2, Dose↑, 1, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers ⓘ
CEA↓, 1, CRP↓, 1, EGFR↑, 1, p‑EGFR↓, 1, FOXM1↓, 1, GutMicro↑, 1, HER2/EBBR2↓, 1, hTERT/TERT↓, 1, IL6↓, 1, IL6↑, 1,
Functional Outcomes ⓘ
AntiCan↑, 1, cardioP↑, 1, cognitive↑, 1, OS↑, 1,
Total Targets: 128
Pathway results for Effect on Normal Cells:
NA, unassigned ⓘ
AntiBio↑, 2,
Redox & Oxidative Stress ⓘ
antiOx↓, 1, antiOx↑, 11, Catalase↑, 11, Ferroptosis↓, 1, GPx↑, 4, GSH↑, 9, GSR↑, 2, GSTs↑, 1, HO-1↑, 6, Keap1↑, 1, lipid-P↓, 6, MDA↓, 4, NQO1↑, 1, NRF2↑, 11, PARK2↑, 1, ROS↓, 20, mt-ROS↓, 1, SIRT3↑, 2, SOD↑, 11, TBARS↓, 1, TrxR↑, 1, uricA↓, 1,
Mitochondria & Bioenergetics ⓘ
ATP↑, 3, MMP↑, 7, mtDam↓, 1, PGC-1α↑, 2,
Core Metabolism/Glycolysis ⓘ
12LOX↓, 1, ALAT↓, 1, AMPK↑, 3, CREB↑, 1, glucose↓, 1, LDH↓, 1, PPARα↝, 1, PPARγ↑, 4,
Cell Death ⓘ
Akt↓, 1, Akt↑, 1, p‑Akt↑, 1, Apoptosis↓, 5, BAX↓, 1, BAX↑, 1, Bax:Bcl2↓, 1, Bcl-2↓, 1, Bcl-2↑, 1, Casp↓, 1, Casp3↓, 3, Casp3↑, 1, Casp9↑, 1, Cyt‑c↓, 1, Ferroptosis↓, 1, iNOS↓, 4, JNK↓, 1, p‑JNK↓, 1, MAPK↓, 3, MCT1↓, 1, necrosis↓, 1, p‑p38↓, 1, TRPV1↑, 1,
Transcription & Epigenetics ⓘ
Ach↑, 2, HATs↓, 1,
Protein Folding & ER Stress ⓘ
CHOP↓, 1, GRP78/BiP↓, 1, GRP78/BiP↑, 1, HSF1↑, 1, HSP70/HSPA5↑, 2, HSPs↑, 1, UPR↑, 1,
Autophagy & Lysosomes ⓘ
MitoP↑, 1, p62↓, 1, p62↑, 1,
DNA Damage & Repair ⓘ
DNMT1↓, 1,
Proliferation, Differentiation & Cell State ⓘ
ERK↑, 1, p‑ERK↓, 1, GSK‐3β↓, 3, HDAC↑, 1, mTOR↓, 1, PI3K↓, 1, PI3K↑, 1,
Migration ⓘ
AP-1↓, 1, APP↓, 1, Ca+2↓, 3, Cartilage↑, 1, MMP13↓, 1, MMP9↓, 1, TG2/TGase↓, 1, TRPC1↓, 1, β-catenin/ZEB1↑, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, NO↓, 1, NO↑, 1,
Barriers & Transport ⓘ
BBB?, 1, BBB↓, 1, BBB↑, 8, GastroP↑, 2, IBI↑, 1,
Immune & Inflammatory Signaling ⓘ
CD4+↑, 1, COX2↓, 8, CRP↓, 1, HMGB1↓, 1, IL1β↓, 12, IL33↓, 1, IL4↓, 1, IL6↓, 7, IL6↑, 2, IL8↓, 1, Imm↑, 1, Inflam↓, 13, NF-kB↓, 9, PGE2↓, 2, TLR4↓, 3, TNF-α↓, 15,
Synaptic & Neurotransmission ⓘ
5HT↑, 1, AChE↓, 6, BChE↓, 2, BDNF↑, 5, BDNF∅, 1, GABA↑, 1, MAOA↓, 2, tau↓, 3, p‑tau↓, 3, TrkB↑, 2,
Protein Aggregation ⓘ
Aβ↓, 20, BACE↓, 4, NLRP3↓, 3,
Drug Metabolism & Resistance ⓘ
BioAv↓, 3, BioAv↑, 6, BioAv↝, 1, eff↑, 9, Half-Life↝, 1,
Clinical Biomarkers ⓘ
ALAT↓, 1, AST↓, 1, BloodF↑, 1, BP↓, 1, creat↓, 1, CRP↓, 1, GutMicro↑, 3, IL6↓, 7, IL6↑, 2, LDH↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 1, cardioP↑, 4, cognitive↑, 10, hepatoP↑, 3, memory↑, 8, motorD↓, 1, motorD↑, 4, neuroP↑, 21, Obesity↓, 1, OS↑, 1, Pain↓, 2, radioP↑, 1, RenoP↑, 2, Risk↓, 4, Strength↑, 2, toxicity↓, 1, toxicity↑, 1,
Infection & Microbiome ⓘ
AntiFungal↑, 1, Bacteria↓, 1, CD8+↑, 1,
Total Targets: 159
Scientific Paper Hit Count for: Aβ, Aβ aggregation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:75 Cells:% prod#:% Target#:1333 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page